We think that Abacus should be your first choice agency when commissioning a NICE, SMC or other HTA submission. Three good reasons include:
Experience
Abacus has been developing NICE submissions since 2000 and SMC submissions since 2003. So far we have completed over 80 HTA submissions to:
- National Institute for Health and Clinical Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicine Strategy Group (AWMSG)
- Pharmaceutical Benefits Board (LFN), Sweden
- Canadian Agency for Drugs and Technologies in Health (CADTH)/ Common Drug Review (CDR)
Success
When it comes to producing a NICE or SMC submission there is no substitute for experience, and here at Abacus International, we have it in abundance.
NICE submissions > 90% product approval
SMC submissions > 80% product approval
SMC resubmissions > 75% product approval
Our expert team has an excellent track record, boasting a substantially higher-than-average success rate (see our latest statistics and further details).
We know what makes a good submission, we know why most submissions fail and we know how to maximise your chances of success.
In-house skills
With in-house health economic expertise
plus a team of skilled medical writers and researchers, we have the knowledge and experience to manage all aspects of your health technology assessment (HTA).
This means that you do not need to use different agencies to develop your systematic review, health economic model and HTA dossier. Abacus will also liaise directly with the HTA agency on your behalf ensuring seamless project management and delivery to deadlines.
